This is a product launch?


anonymous

Guest
It seems like Akorn barely has anything together. No sales aids, no sales processing, no current customer list, no demo. Where is the sales messaging? Where are the journal ads? Where is the buzz? We are turning this out like a 3 man company from the 1980s. Disappointing.
 










The culture and company have never been better with that idiot gone.

maybe he was a bit of a jerk, but at least he wouldn’t have launched a product with no sales aids, no processes, no training etc. It’s great to have someone who is nice, but how about someone who acts like a human to other people AND knows how to launch a product.
 


Nice? Ron was a tyrant, was completely out of touch with the reality of what happens in the field. He spent money on training materials that most reps never used. His messaging was archaic. Our new management may be new to sales and product launches but exhibits more human behavior than Ron ever did. It’s a learning curve now. We will get where we need to be.
 


Nice? Ron was a tyrant, was completely out of touch with the reality of what happens in the field. He spent money on training materials that most reps never used. His messaging was archaic. Our new management may be new to sales and product launches but exhibits more human behavior than Ron ever did. It’s a learning curve now. We will get where we need to be.

Not saying he was nice. Said he was a jerk, but maybe we would have had more than 2 sales aids for example when we launched . I am saying maybe JB is a little nicer, but she doesn’t know how to launch a product. Neither one of them are/did do a good job. Either way what we have now is a mess.
 










The sales directors need to report what’s truly happening in the field back to JB instead of them trying to cover their own asses. Most (not all) of these directors are not telling JB what’s happening in the field, she needs/wants to know reality.
 






JB has no clue- is a shill for the Jersey Boys who thought they could save this pig. The BOD has seen enough with poor plant performance, massive turnover rate, no FDA site approvals, writing is on the wall.
 











Write your reply...